Back to Journals » OncoTargets and Therapy » Volume 17

Efficacy and Safety of the MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series

Total article views   HTML views PDF downloads Totals
1,496 Dovepress* 1,496+ 23 1,519
Totals 1,496 23 1,519
*Since 29 March 2024
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed Central and Google Scholar